MERIT Webinar: RECIST 1.1 & Oncology Trial Endpoints

RECIST 1.1 is the standard response criteria for solid tumors and has been a basis for adaptation and variation of other response criteria such as mRECIST, irRECIST, iRECIST, and so on. In this webinar, MERIT discusses the principles of RECIST 1.1, the information needed to collect imaging endpoints, and special considerations while using the RECIST 1.1 criteria.

[@VinodKumar-re6jc]

Hi Dr. Gene Kim,
It is such a great and informative presentation.
Can you help me to share these slides ?

[@alfred3432]

can I use RECIST 1.1 if no baseline studies are available? I often receive cases with no pretreatment images.

[@user-mj4gs9uq4h]

Good presentation!